Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease, Movement Disorders, vol.44, issue.3, pp.552-60, 2000. ,
DOI : 10.1002/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P
Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein, Nature Biotechnology, vol.257, issue.3, pp.256-63, 2010. ,
DOI : 10.1038/nbt.1608
Involvement of Mitochondrial Complex II Defects in Neuronal Death Produced by N-Terminus Fragment of Mutated Huntingtin, Molecular Biology of the Cell, vol.17, issue.4, pp.1652-63, 2006. ,
DOI : 10.1091/mbc.E05-07-0607
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice, Proceedings of the National Academy of Sciences, vol.97, issue.12, pp.6809-6823, 2000. ,
DOI : 10.1073/pnas.120166397
Importance of a Novel Oxidative Mechanism for Elimination of Brain Cholesterol: TURNOVER OF CHOLESTEROL AND 24(S)-HYDROXYCHOLESTEROL IN RAT BRAIN AS MEASURED WITH 18O2TECHNIQUES IN VIVO AND IN VITRO, Journal of Biological Chemistry, vol.272, issue.48, pp.30178-84, 1997. ,
DOI : 10.1074/jbc.272.48.30178
Brain Cholesterol: Long Secret Life Behind a Barrier, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.5, pp.806-821, 2004. ,
DOI : 10.1161/01.ATV.0000120374.59826.1b
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor, Cell, vol.89, issue.3, pp.331-371, 1997. ,
DOI : 10.1016/S0092-8674(00)80213-5
Unraveling a role for dopamine in Huntington's disease: The dual role of reactive oxygen species and D2 receptor stimulation, Proceedings of the National Academy of Sciences, vol.102, issue.34, pp.12218-12241, 2005. ,
DOI : 10.1073/pnas.0502698102
Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit, Prenatal Diagnosis, vol.37, issue.11, pp.1000-1006, 2005. ,
DOI : 10.1002/pd.1254
Transcriptional Repression of PGC-1?? by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration, Cell, vol.127, issue.1, pp.59-69, 2006. ,
DOI : 10.1016/j.cell.2006.09.015
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation, Cell, vol.90, issue.3, pp.537-585, 1997. ,
DOI : 10.1016/S0092-8674(00)80513-9
Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington???s disease, Journal of Neurochemistry, vol.60, issue.1, pp.153-67, 2010. ,
DOI : 10.1111/j.1471-4159.2010.06912.x
Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation, PLoS ONE, vol.4, issue.12, p.8287, 2009. ,
DOI : 10.1371/journal.pone.0008287.g007
Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal, The Journal of Lipid Research, vol.45, issue.8, pp.1375-97, 2004. ,
DOI : 10.1194/jlr.R400004-JLR200
CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer???s disease, Brain, vol.138, issue.8, pp.2383-98, 2015. ,
DOI : 10.1093/brain/awv166
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease, Science, vol.296, issue.5576, pp.2238-2281, 2002. ,
DOI : 10.1126/science.1072613
Time course of oxysterol formation during in vitro oxidation of low density lipoprotein, Chemistry and Physics of Lipids, vol.78, issue.2, pp.119-147, 1995. ,
DOI : 10.1016/0009-3084(95)02489-6
Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules, Cell, vol.118, issue.1, pp.127-165, 2004. ,
DOI : 10.1016/j.cell.2004.06.018
Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells, Journal of Biological Chemistry, vol.278, issue.50, pp.50514-50536, 2003. ,
DOI : 10.1074/jbc.M309348200
Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease, Molecular Therapy, vol.18, issue.1, pp.44-53, 2010. ,
DOI : 10.1038/mt.2009.175
GRP78 counteracts cell death and protein aggregation caused by mutant huntingtin proteins, Neuroscience Letters, vol.516, issue.2, pp.182-189, 2012. ,
DOI : 10.1016/j.neulet.2012.03.074
Cholesterol metabolism in Huntington disease, Nature Reviews Neurology, vol.328, issue.10, pp.561-72, 2011. ,
DOI : 10.1038/nrneurol.2011.132
Serum lathosterol concentration is an indicator of wholebody cholesterol synthesis in humans, J Lipid Res, vol.29, pp.1149-55, 1988. ,
Lipid rafts, cholesterol, and the brain, Neuropharmacology, vol.55, issue.8, pp.1265-73, 2008. ,
DOI : 10.1016/j.neuropharm.2008.02.019
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage, Human Molecular Genetics, vol.16, issue.15, pp.1845-61, 2007. ,
DOI : 10.1093/hmg/ddm133
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease, Brain, vol.131, issue.11, pp.2851-2860, 2008. ,
DOI : 10.1093/brain/awn212
Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression, Neurobiology of Disease, vol.55, pp.37-43, 2013. ,
DOI : 10.1016/j.nbd.2013.03.013
The impairment of cholesterol metabolism in Huntington disease, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.8, pp.1095-105, 2015. ,
DOI : 10.1016/j.bbalip.2014.12.018
Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice, J Neurosci, vol.21, pp.8473-81, 2001. ,
Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease, Cell Death and Differentiation, vol.12, issue.3, pp.416-443, 2012. ,
DOI : 10.1139/o59-099
cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain, Proceedings of the National Academy of Sciences, vol.96, issue.13, pp.7238-7281, 1999. ,
DOI : 10.1073/pnas.96.13.7238
Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover, Journal of Biological Chemistry, vol.278, issue.25, pp.22980-22988, 2003. ,
DOI : 10.1074/jbc.M303415200
Cholesterol Loss Enhances TrkB Signaling in Hippocampal Neurons Aging in Vitro, Molecular Biology of the Cell, vol.19, issue.5, pp.2101-2113, 2008. ,
DOI : 10.1091/mbc.E07-09-0897
Autophagy in Huntington disease and huntingtin in autophagy, Trends in Neurosciences, vol.38, issue.1, pp.26-35, 2015. ,
DOI : 10.1016/j.tins.2014.09.003
Pitfalls in the detection of cholesterol in Huntington???s disease models, PLoS Currents, vol.4, pp.505886-505895, 2012. ,
DOI : 10.1371/505886e9a1968
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models, Neurobiology of Disease, vol.35, issue.3, pp.319-355, 2009. ,
DOI : 10.1016/j.nbd.2009.05.007
Multiple Aspects of Gene Dysregulation in Huntington???s Disease, Frontiers in Neurology, vol.4, p.127, 2013. ,
DOI : 10.3389/fneur.2013.00127
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease, Trends in Neurosciences, vol.33, issue.11, pp.513-536, 2010. ,
DOI : 10.1016/j.tins.2010.08.002
Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats, Journal of Neurochemistry, vol.281, issue.1, pp.125-159, 2009. ,
DOI : 10.1111/j.1471-4159.2009.05917.x
URL : https://hal.archives-ouvertes.fr/hal-00400252
gene transcription, Journal of Neurochemistry, vol.63, issue.2, pp.418-449, 2010. ,
DOI : 10.1111/j.1471-4159.2010.06612.x
Cystathionine ??-lyase deficiency mediates neurodegeneration in Huntington???s disease, Nature, vol.26, issue.7498, pp.96-100, 2014. ,
DOI : 10.1038/nature13136
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial, The Lancet, vol.383, issue.9923, pp.1138-1184, 2014. ,
DOI : 10.1016/S0140-6736(13)61939-X
Role of cholesterol in synapse formation and function, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1610, issue.2, pp.271-80, 2003. ,
DOI : 10.1016/S0005-2736(03)00024-5
Alzheimer's disease: the cholesterol connection, Nature Neuroscience, vol.6, issue.4, pp.345-51, 2003. ,
DOI : 10.1038/nn0403-345
Control of the Postsynaptic Membrane Viscosity, Journal of Neuroscience, vol.29, issue.9, pp.2926-2963, 2009. ,
DOI : 10.1523/JNEUROSCI.4445-08.2009
Protein aggregation and neurodegenerative disease, Nature Medicine, vol.99, issue.7, pp.10-17, 2004. ,
DOI : 10.1038/nm1066
Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments, Curr Opin Neurol, vol.21, pp.497-503, 2008. ,
Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death, The FASEB Journal, vol.22, issue.4, pp.1083-93, 2008. ,
DOI : 10.1096/fj.07-9814
URL : https://hal.archives-ouvertes.fr/hal-00258860
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models, Human Molecular Genetics, vol.16, issue.11, pp.1293-306, 2007. ,
DOI : 10.1093/hmg/ddm078
Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain, Journal of Neuropathology & Experimental Neurology, vol.60, issue.2, pp.161-72, 2001. ,
DOI : 10.1093/jnen/60.2.161
Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo, Journal of Internal Medicine, vol.201, issue.4, pp.377-87, 2011. ,
DOI : 10.1111/j.1365-2796.2011.02389.x
Cholesterol in Alzheimer's disease, The Lancet Neurology, vol.4, issue.12, pp.841-52, 2005. ,
DOI : 10.1016/S1474-4422(05)70248-9
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses, Human Molecular Genetics, vol.11, issue.17, pp.1953-65, 2002. ,
DOI : 10.1093/hmg/11.17.1953
Enhanced Survival of the LINCL Mouse Following CLN2 Gene Transfer Using the rh.10 Rhesus Macaque-derived Adeno-associated Virus Vector, Molecular Therapy, vol.15, issue.3, pp.481-91, 2007. ,
DOI : 10.1038/sj.mt.6300049
Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses, Cell, vol.151, issue.1, pp.138-52, 2012. ,
DOI : 10.1016/j.cell.2012.06.054
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice, The Journal of Comparative Neurology, vol.87, issue.4, pp.354-70, 2005. ,
DOI : 10.1002/cne.20680
Brain-Derived Neurotrophic Factor Regulates Cholesterol Metabolism for Synapse Development, Journal of Neuroscience, vol.27, issue.24, pp.6417-6444, 2007. ,
DOI : 10.1523/JNEUROSCI.0690-07.2007
The Wnt Receptor Ryk Reduces Neuronal and Cell Survival Capacity by Repressing FOXO Activity During the Early Phases of Mutant Huntingtin Pathogenicity, PLoS Biology, vol.11, issue.19, p.1001895, 2014. ,
DOI : 10.1371/journal.pbio.1001895.s020
URL : https://hal.archives-ouvertes.fr/hal-01076146
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells, Human Molecular Genetics, vol.9, issue.19, pp.2799-809, 2000. ,
DOI : 10.1093/hmg/9.19.2799
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo, Human Molecular Genetics, vol.15, issue.24, pp.3578-91, 2006. ,
DOI : 10.1093/hmg/ddl434
Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo, Human Molecular Genetics, vol.23, issue.1, pp.129-173, 2014. ,
DOI : 10.1093/hmg/ddt406
PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function, Sci Transl Med, vol.4, pp.142-97, 2012. ,
Suppression of amyloid-?? production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking, The FASEB Journal, vol.27, issue.10, pp.4305-4320, 2013. ,
DOI : 10.1096/fj.13-231456
Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease, Journal of Neuroscience, vol.25, issue.43, pp.9932-9941, 2005. ,
DOI : 10.1523/JNEUROSCI.3355-05.2005
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation, Human Molecular Genetics, vol.16, issue.18, pp.2187-98, 2007. ,
DOI : 10.1093/hmg/ddm170
Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington???s disease, Neurobiology of Disease, vol.28, issue.1, pp.133-175, 2007. ,
DOI : 10.1016/j.nbd.2007.07.004
Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes, Journal of Neuroscience, vol.30, issue.32, pp.10844-50, 2010. ,
DOI : 10.1523/JNEUROSCI.0917-10.2010
Emerging roles for cholesterol in Huntington's disease, Trends in Neurosciences, vol.34, issue.9, pp.474-86, 2011. ,
DOI : 10.1016/j.tins.2011.06.005
Neuropathological Classification of Huntington??s Disease, Journal of Neuropathology and Experimental Neurology, vol.44, issue.6, pp.559-77, 1985. ,
DOI : 10.1097/00005072-198511000-00003
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 ?? Contributes to Dysmyelination in Experimental Models of Huntington's Disease, Journal of Neuroscience, vol.31, issue.26, pp.9544-53, 2011. ,
DOI : 10.1523/JNEUROSCI.1291-11.2011
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease, Science, vol.293, issue.5529, pp.493-501, 2001. ,
DOI : 10.1126/science.1059581